| Application no. and date | 05722772.0 (espacenet) (Federated) (European Patent Register), 20050204 | | Patent/reg. no. and date | DK/EP 1711481, 20091230 | | Publication date | 20061018 | | Priority no. and date | US 542490 P, 20040206, US 624937 P, 20041104 | | EP pub. no. and date |
EP 1711481 20061018 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | | Applicant ref. no. | 12276-7 | | Inventor | DIMARCO, John, D., 16 Neal Drive
East Brunswick, NJ 08816, US,
CHEN, Bang-Chi, 28 Maion Dr.
Plainsboro, NJ 08536, US,
DROGHINI, Roberto, 39 Galilee
Candiac, Quebec J5R 3T5, CA,
LAJEUNESSE, Jean, 178 Mermoz
Candiac, Quebec J5R 4T2, CA,
GALELLA, Michael, 54 Chipper Drive
Kendall Park, NJ 08824, US,
CHIDAMBARAM, Ramakrishnan, 56 Stanford Road East
Pennington, NJ 08534, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/506 (2006.01) | | Title | Krystallinsk monohydrat som kinaseinhibitorer | | Int. application no. | US2005003728 | | Int. publication no. | WO2005077945 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
